Company profile FBRX
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Forte Biosciences expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 27 | 41 51.9% QoQ | 15 -63.4% QoQ | 24 60.0% QoQ |
| 2020 | 56 107.4% YoY 133.3% QoQ | 43 4.9% YoY -23.2% QoQ | 72 380.0% YoY 67.4% QoQ | 40 66.7% YoY -44.4% QoQ |
| 2021 | 61 8.9% YoY 52.5% QoQ | 31 -27.9% YoY -49.2% QoQ | 233 223.6% YoY 651.6% QoQ | 111 177.5% YoY -52.4% QoQ |
| 2022 | 25 -59.0% YoY -77.5% QoQ | 26 -16.1% YoY 4.0% QoQ | 54 -76.8% YoY 107.7% QoQ | 50 -55.0% YoY -7.4% QoQ |
| 2023 | 25 0.0% YoY -50.0% QoQ | 43 65.4% YoY 72.0% QoQ | 48 -11.1% YoY 11.6% QoQ | 36 -28.0% YoY -25.0% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Forte Biosciences was 4.07 per week. The last year interest of Forte Biosciences compared to the last 5 years has changed by -35.63%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 16.44%.
There is not enough data for FB-102 program to provide analysis
There is not enough data for FB-102 program to provide correlation calculation
There is not enough data for FB-102 program to provide analysis
There is not enough data for Graft-versus-host disease treatment to provide analysis
There is not enough data for Graft-versus-host disease treatment to provide correlation calculation
There is not enough data for Graft-versus-host disease treatment to provide analysis
After 39 days of this quarter the interest is at 220.0. Based on that we can calculate that during remaining 52 days it will total up to 513.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 217 | 429 97.7% QoQ | 507 18.2% QoQ | 368 -27.4% QoQ |
| 2020 | 304 40.1% YoY -17.4% QoQ | 357 -16.8% YoY 17.4% QoQ | 472 -6.9% YoY 32.2% QoQ | 372 1.1% YoY -21.2% QoQ |
| 2021 | 440 44.7% YoY 18.3% QoQ | 666 86.6% YoY 51.4% QoQ | 725 53.6% YoY 8.9% QoQ | 407 9.4% YoY -43.9% QoQ |
| 2022 | 409 -7.0% YoY 0.5% QoQ | 627 -5.9% YoY 53.3% QoQ | 814 12.3% YoY 29.8% QoQ | 518 27.3% YoY -36.4% QoQ |
| 2023 | 592 44.7% YoY 14.3% QoQ | 749 19.5% YoY 26.5% QoQ | 700 -14.0% YoY -6.5% QoQ | 563 8.7% YoY -19.6% QoQ |
| 2024 | 220 -62.8% YoY -60.9% QoQ | - | - | - |
The average 5 years interest of Vitiligo treatment was 40.06 per week. The last year interest of Vitiligo treatment compared to the last 5 years has changed by 26.78%. The interest for Vitiligo treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 62.11%.
After 39 days of this quarter the interest is at 176.0. Based on that we can calculate that during remaining 52 days it will total up to 411.0. Alopecia areata treatment expected interest is significantly higher compared to previous quarter (+100.5%) and same quarter last year (+85.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 93 | 169 81.7% QoQ | 169 0.0% QoQ | 161 -4.7% QoQ |
| 2020 | 153 64.5% YoY -5.0% QoQ | 185 9.5% YoY 20.9% QoQ | 173 2.4% YoY -6.5% QoQ | 204 26.7% YoY 17.9% QoQ |
| 2021 | 188 22.9% YoY -7.8% QoQ | 123 -33.5% YoY -34.6% QoQ | 197 13.9% YoY 60.2% QoQ | 171 -16.2% YoY -13.2% QoQ |
| 2022 | 252 34.0% YoY 47.4% QoQ | 251 104.1% YoY -0.4% QoQ | 265 34.5% YoY 5.6% QoQ | 217 26.9% YoY -18.1% QoQ |
| 2023 | 222 -11.9% YoY 2.3% QoQ | 191 -23.9% YoY -14.0% QoQ | 223 -15.8% YoY 16.8% QoQ | 205 -5.5% YoY -8.1% QoQ |
| 2024 | 176 -20.7% YoY -14.1% QoQ | - | - | - |
The average 5 years interest of Alopecia areata treatment was 15.28 per week. The last year interest of Alopecia areata treatment compared to the last 5 years has changed by 13.87%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 35.09%.
There is not enough data for Forte Biosciences stock price to provide analysis
There is not enough data for Forte Biosciences stock price to provide correlation calculation
There is not enough data for Forte Biosciences stock price to provide analysis
There is not enough data for Forte Biosciences clinical trials to provide analysis
There is not enough data for Forte Biosciences clinical trials to provide correlation calculation
There is not enough data for Forte Biosciences clinical trials to provide analysis
After 39 days of this quarter the interest is at 50.0. Based on that we can calculate that during remaining 52 days it will total up to 117.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 27 | 118 337.0% QoQ | 87 -26.3% QoQ | 48 -44.8% QoQ |
| 2020 | 130 381.5% YoY 170.8% QoQ | 99 -16.1% YoY -23.8% QoQ | 113 29.9% YoY 14.1% QoQ | 110 129.2% YoY -2.7% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 117 18.2% YoY inf% QoQ | 195 72.6% YoY 66.7% QoQ | 86 -21.8% YoY -55.9% QoQ |
| 2022 | 49 inf% YoY -43.0% QoQ | 33 -71.8% YoY -32.7% QoQ | 170 -12.8% YoY 415.2% QoQ | 158 83.7% YoY -7.1% QoQ |
| 2023 | 141 187.8% YoY -10.8% QoQ | 57 72.7% YoY -59.6% QoQ | 31 -81.8% YoY -45.6% QoQ | 173 9.5% YoY 458.1% QoQ |
| 2024 | 50 -64.5% YoY -71.1% QoQ | - | - | - |
The average 5 years interest of Forte Biosciences news was 7.63 per week. The last year interest of Forte Biosciences news compared to the last 5 years has changed by 6.42%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 15.67%.
There is not enough data for Forte Biosciences reviews to provide analysis
There is not enough data for Forte Biosciences reviews to provide correlation calculation
There is not enough data for Forte Biosciences reviews to provide analysis
There is not enough data for Forte Biosciences contact to provide analysis
There is not enough data for Forte Biosciences contact to provide correlation calculation
There is not enough data for Forte Biosciences contact to provide analysis